BioAdvance Names Dr. Philip P. Gerbino Chair and Elects Dr. John M. Daly to Board of Directors Read more here
Read More
QR Pharma Inc. Exclusively Licenses Clinical Stage Compounds Posiphen®, Bisnorcymserine and Phenserine to Treat Alzheimer’s Disease Read more here
Read More
TorreyPines Therapeutics Licenses Posiphen®, Bisnorcymcerine and Phenserine to QR Pharma Read more here
Read More
Jenrin Discovery’s Non-Brain Penetrant Cb1 Antagonists Show Beneficial Effects in Treating Diabetes and Obesity Read more here
Read More
InfraScan Launches International Sales of a Handheld Brain Hematoma Detector Read more here
Read More
InfraScanner: Star Trek Style Scanner Looks for Clots Read more here
Read More
NuPathe Inc. CEO to Present at the Leerink Swann Emerging Technologies in Pain Medicine Conference Read more here
Read More
Protez Pharmaceuticals to be Acquired by Novartis Read more here
Read More
County Biopharmaceutical Firm Protez to be Bought Read more here
Read More
Novartis to Acquire Protez for Up to $400 Million Read more here
Read More
Tips for Emerging Firms on Obtaining Funding Read more here
Read More
Melior Discovery Enters New Pharmaceutical Collaboration Read more here
Read More
Melior Enters Research Collaboration with Pfizer Read more here
Read More
InfraScan to Present at “Investment In Innovation (In3) WEST” Conference Read more here
Read More
NuPathe Licenses Novel Drug Delivery Technology from University of Pennsylvania Read more here
Read More